TechBio x AI Drug Discovery: From Concept to Reality
Morning Coffee with Fanny Jaulin, founder of Orakl Oncology
Morning Coffee with Bradley Treeby, Co-Founder and CEO of NeuroHarmonics
Longevity & Healthy Ageing Report: How Tech is Helping us Live Longer and Healthier Lives
Smart Solutions in Healthcare: How AI is Shaping the Future of Medicine
TechBio X Drug Discovery: Developing New Drugs Faster and Cheaper
Behind the Rise of Femtech: Untangling the Increased Investment in the Industry
We Mapped Non-Dilutive Funding in 25-Plus European Countries
Our Comprehensive Collection of European Healthtech Accelerators and Incubators
Three Takeaways From Our Report on Startups Addressing Clinical Capacity Bottlenecks
Digital Therapeutics Is Now the Fastest-Growing Segment in Healthtech
Top Early-Stage European Healthtech VC Funds
Does the Term “Femtech” Help or Hinder?
Digital Health in Europe: How the UK is Leading the Digital Transformation of Healthcare
Digital Health in Europe: A Record-Breaking Year for Founders & Investors in DACH
Digital Health Exits in Europe: End of 2021 Update
Digital Health in Europe: Southern Europe is Picking up the Pace
Digital Health in Europe: Cautiously Bullish in BeNeLux
Andrea Zitna Joins Speedinvest Health Team: Why Switch Sides?
EQ Beats IQ: Our Investment in ahead
Digital Health in Europe: The Untapped Potential of CEE
Market Spotlight: The Future of Femtech in the US and EU
Digital Health Exits in Europe: Q1 2021 Update
Digital Health in Europe: Reforms are Accelerating the DACH Market
Taking Back Control of Your Phone: Our Investment in Opal
Incubators and Accelerators are Driving Digital Health in France
Digital Health in Europe: The Landscape in France
Digital Health Exits in Europe: 10 Years Just Happened in 12 Months
Digital Health in Europe: Analysis of 600+ Startups from the Last Decade
Speedinvest’s Digital Health in Europe Blog Series: Data and Methods
COVID-19 and the Future of Telehealth in the German Speaking World
All
